Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 2 , Pages 145-149 , March 2012

Tumor cytoreduction results in better response to androgen ablation—a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer

  • Xiao-Jian Qin, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Chun-Guang Ma, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Ding-Wei Ye, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
    • Corresponding Author InformationCorresponding author. Tel.: +862164175590; fax: +862164175590
  • ,
  • Xu-Dong Yao, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Shi-Lin Zhang, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Bo Dai, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Hai-Liang Zhang, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Yi-Jun Shen, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Yao Zhu, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Yi-Ping Zhu, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Guo-Hai Shi, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Wen-Jun Xiao, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Guo-Wen Lin, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Gregory P. Swanson, M.D.

      Affiliations

    • Department of Radiology and Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA

Received 2 November 2009 ,Revised 6 February 2010 ,Accepted 10 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(10)00051-7

doi: 10.1016/j.urolonc.2010.02.010

Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 2 , Pages 145-149 , March 2012